Advisory - RestoraLAX 45 + 10 Value Pack sold at Costco Canada recalled due to potential choking hazard
OTTAWA, July 2, 2017 /CNW/ -
Issue Health Canada is advising Canadians that Bayer Inc. is voluntarily recalling RestoraLAX 45 + 10 Value Pack sold at Costco Canada due to a potential choking hazard. The recalled product may contain deposits such as clumps or lumps.? The presence of these deposits may pose a choking hazard.
RestoraLAX is used to relieve occasional constipation and irregularity.
Who is affected
Consumers who have bought or used RestoraLAX 45 + 10 Value Pack? sold at Costco Canada.
Affected products RestoraLAX 45 + 10 Value Pack (DIN: 02318164?)
This product is sold as a combination pack: 1 bottle of 45 Dose RestoraLAX and 1 box of 10 single dose sachets of RestoraLAX shrink wrapped together for sale by Costco Canada only.
What consumers should do
Stop using this product. If you experience difficulty swallowing or breathing after taking this product, seek immediate medical attention.
Consult with your health care professional if you have used it and have health concerns.
Report adverse events to health products to Health Canada by calling toll-free at 1?866?234?2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1?800?267?9675, or complete an online complaint form.
What Health Canada is doing Health Canada is monitoring the company's recall. If new safety information is identified, Health Canada will take appropriate action and inform Canadians.
For more information Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...